Nonclinical Studies

Plan your next nonclinical study or partner with us for an IND-/CTA-enabling package to get you from research to clinical trials faster.

Contact Us


Online catalog

Search for nonclinical assays and studies in the online catalog. 

Nonclinical lab facilities

Access global capacity for your nonclinical reserach studies. 



Featured Solutions


Your partnering journey starts here

Start strategic conversations that kick-start partnering with the help of MarketPlace by Labcorp. One connection is made every month in our complimentary innovative platform that connects asset providers and asset seekers. Learn how MarketPlace can propel your path forward.

Early Development Investments

Making your breakthroughs possible with investments that matter 

See how Labcorp is investing worldwide in nonclinical development and how these innovations all started by listening to you and appreciating your changing requirements.


Oncology models and cell lines

Advance your preclinical oncology compounds with a comprehensive suite of preclinical oncology studies, including in vitro and in vivo pharmacology efficacy models, in vivo imaging technologies as well as focal radiation capabilities.


Inhalation testing capabilities

Inhalation toxicology studies are becoming vital in assessing the safety and potential toxicity of inhaled drugs or chemicals as respiratory diseases including asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) become more common.


IND-/CTA-enabling packages

Accelerate your molecule’s success with early phase development solutions that help to advance your molecule swiftly through critical milestones while maximizing the asset's value. Shave off as much as 30% on your early drug development timeline.


By the Numbers


studies in 2022 (Early Development Research Laboratories)


global biotech and pharmaceutical partners supported each year (ED + CLS, inclusive of BioA and CMC)

Deep science for complex research challenges.

"Labcorp is a dependable and reliable source for complicated studies with dedicated and extremely competent study direction.” – Project leader from a global pharmaceutical company


Have Questions?

Let's start a conversation

Contact Us